Results 221 to 230 of about 2,278,305 (352)
We developed and validated a DNA methylation–based biomarker panel to distinguish pleural mesothelioma from other pleural conditions. Using the IMPRESS technology, we translated this panel into a clinically applicable assay. The resulting two classifier models demonstrated excellent performance, achieving high AUC values and strong diagnostic accuracy.
Janah Vandenhoeck +12 more
wiley +1 more source
Evaluating Generative AI Psychotherapy Chatbots Used by Youth: Cross-Sectional Study.
Sobowale K, Humphrey DK, Zhao SY.
europepmc +1 more source
Constructing dyadic management behavioral personas for patient-caregiver dyads in ambulatory chemotherapy: A qualitative study. [PDF]
Yu T, Zhang X, Wang L, Lu Z.
europepmc +1 more source
Strength through diversity: how cancers thrive when clones cooperate
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken +3 more
wiley +1 more source
Editorial: Why the randomized controlled trial is still at the apex and the gold standard for evaluating new medical and surgical interventions. [PDF]
Reito A, Overgaard S.
europepmc +1 more source
The Persona of the Jurist in Salmond's Jurisprudence: On the Exposition of "What law is ..."
Shaunnagh Dorsett, Shaun McVeigh
openalex +2 more sources
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto +8 more
wiley +1 more source

